Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Rapid improvements in blood sugar control after starting insulin can temporarily aggravate nerve pain by stressing tiny blood vessels, triggering inflammation and disrupting nerve signaling, especially in people with long-standing high A1C or pre-existing neuropathy.
Gradual insulin titration, careful glucose monitoring, and targeted pain management can help reduce this insulin-related neuropathy flare. See below for detailed risk factors, symptom timelines, and step-by-step strategies to guide your next steps in care.
Starting insulin therapy can be a big step toward better blood sugar control for people with diabetes. Yet, paradoxically, some individuals report a flare-up of nerve pain—often called "insulin and nerve pain flare"—shortly after beginning insulin. Understanding why this happens, what to watch for, and how to manage it can help you stay on track with treatment without undue discomfort.
When people with diabetes start—or intensify—insulin therapy, they sometimes experience a sudden increase in burning, tingling, or shooting pains in their hands, feet, or elsewhere. Clinicians refer to this as treatment-induced neuropathy in diabetes (TIND), or "insulin neuritis." It's a temporary worsening of nerve pain thought to be linked to rapid improvement in blood sugar levels.
While research is ongoing, experts point to several factors that may contribute to nerve pain flares after starting insulin:
• Rapid glucose shifts
– Quickly moving from high blood sugar (hyperglycemia) to near-normal levels can stress small blood vessels that supply nerves.
– This "relative ischemia" may trigger nerve injury or inflammation.
• Osmotic and metabolic changes
– Fast changes in blood sugar alter the concentration of glucose and other substances in nerve cells and surrounding tissues.
– These shifts can disrupt nerve signaling and lead to pain.
• Microvascular and inflammatory responses
– Improved glucose control changes blood flow patterns.
– Tiny blood vessels (capillaries) may constrict or leak, triggering local inflammation around nerves.
• Underlying nerve damage
– Long-standing high blood sugar often causes subclinical damage to nerves.
– When metabolic control suddenly improves, injured nerves may react more painfully before they begin to heal.
Not everyone starting insulin will develop a pain flare. Certain factors increase the likelihood:
• Long duration of poorly controlled diabetes
• Very high A1C levels before insulin (often > 10%)
• Pre-existing neuropathy symptoms (numbness, tingling)
• Rapid dosing increases or aggressive insulin titration
• Other microvascular complications (retinopathy, nephropathy)
If you recognize these risk factors in yourself, you and your healthcare team can plan a gentler approach to insulin initiation.
Most people who experience an insulin-related neuropathy flare notice symptoms within days to weeks after insulin doses are ramped up. Common complaints include:
• Burning or "electric" pains in feet, legs, hands, or arms
• Heightened sensitivity to touch (allodynia)
• Night-time worsening of symptoms
• Sudden onset or rapid worsening of existing neuropathy
This flare often peaks around 4–8 weeks after starting or intensifying insulin, then gradually improves over several months as nerves adapt and small vessels stabilize.
While you may not be able to eliminate nerve pain completely, a balanced plan can lessen its severity and help you stay on insulin:
Coordinate insulin dosing with gradual targets
Choose an appropriate insulin regimen
Monitor blood sugar carefully
Manage nerve pain symptomatically
Supportive lifestyle measures
Consider therapeutic options
Though nerve pain flares can be distressing, most people notice gradual relief:
• 2–3 months: Beginning of stabilization as microvascular function improves
• 3–6 months: Noticeable reduction in burning or shooting pains
• 6–12 months: Many patients return to their pre-flare level of nerve discomfort
If pain persists or worsens beyond a year, re-evaluation for other causes of neuropathy is advisable.
Prompt communication with your healthcare team is key:
• Sudden, severe increase in pain interfering with daily activities
• Signs of infection, open sores, or loss of protective sensation in feet
• Symptoms of very low blood sugar (confusion, sweating, shakiness)
• Any concern that could be life-threatening or seriously affecting your health
If you're experiencing new or worsening symptoms and want personalized guidance before your next appointment, try this Medically Approved LLM Symptom Checker Chat Bot to better understand what you're experiencing and determine the right level of care.
• Rapid improvements in blood sugar can temporarily aggravate nerve pain (insulin and nerve pain flare).
• Risk is higher with long-standing hyperglycemia and aggressive insulin titration.
• A gradual, carefully monitored insulin plan and targeted pain management can ease the flare.
• Most people experience relief within months as nerves and small vessels adapt.
• Always speak to a doctor about any severe, persistent, or life-altering symptoms.
Insulin therapy remains one of the most effective tools for long-term diabetes management. By understanding why and how nerve pain flares occur, you can work with your care team to minimize discomfort and reap the full benefits of better blood sugar control.
Remember: speak to a doctor about anything that could be life-threatening or serious.
(References)
* Rajabally YA, et al. Insulin neuritis: The paradox of worsening neuropathy with improved glycemic control. Pract Neurol. 2019 Jun;19(3):233-238. doi: 10.1136/practneurol-2018-002030. Epub 2018 Jul 23. PMID: 30040716.
* Papanas N, et al. Treatment-emergent neuropathy: A narrative review of an increasingly recognized complication of diabetes treatment. Metabolism. 2021 Apr;117:154721. doi: 10.1016/j.metabol.2021.154721. Epub 2021 Feb 6. PMID: 33580459.
* El Zoghbi N, et al. Acute painful neuropathy in type 1 diabetes after initiation of insulin: a case report and review of the literature. J Med Case Rep. 2021 Aug 20;15(1):433. doi: 10.1186/s13256-021-03009-w. PMID: 34415516; PMCID: PMC8377759.
* Ali Z, et al. The enigma of rapid glycaemic control-induced neuropathy: A review of aetiology, clinical presentation, and management. Pract Neurol. 2023 Dec;23(6):448-456. doi: 10.1136/pn-2023-003884. Epub 2023 Aug 29. PMID: 37637403.
* Papanas N, et al. Insulin neuritis: The mechanism behind the pain. Cleve Clin J Med. 2019 Jan;86(1):64-68. doi: 10.3949/ccjm.86a.18029. PMID: 30678335.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.